These data thus suggest that GLP-1 has a good amplifying effect on glucose-stimulated insulin release but might be less efficient in strengthening glucose-induced glucagon suppression in vivo in this model of type 2 diabetes. The gene discussed is GCG; the disease is type 2 diabetes mellitus.